The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations. 

RBMA President-elect Pete Moffatt discusses how to contend with challenges such as staff shortages and reimbursement issues.

To their reasons for seeking a retrial in the Maya Kowalski case, attorneys for Johns Hopkins All Children’s Hospital in Florida have added a juror’s possibly mischievous and bias-revealing courtroom notes.

A pharmacy benefit management company founded less than five years ago is teaming up with a drug pricing disrupter that will mark its second birthday next month.

More than two-thirds of hospital executives, 70%, say their institution has a formal or comprehensive strategy in place for selecting, acquiring and integrating digital health products.

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

Americans aren’t OK with generative healthcare AI that was developed without physicians and is sold by vendors without track records. 

Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

Former Kaiser Permanente nurse Maria Gatchalian will receive $11.49 million in compensatory damages from her ex-employer, $9 million of which is to make amends for emotional distress, along with some $30 million in punitive damages.

Big as it is, the hospital piece represented just a 2.2% bump over 2021—a modest increase compared with 2021’s spike of 4.5% over 2020.